Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Al Ali NH"'
Autor:
Komrokji RS; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Lanino L; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Ball S; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Bewersdorf JP; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Marchetti M; Azienda Ospedaliera Nazionale SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Maggioni G; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Travaglino E; IRCCS Polilcinico San Matteo, Pavia, Italy., Al Ali NH; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Fenaux P; Saint Louis Hospital, Paris Cité University, Paris, France., Platzbecker U; University Hospital Leipzig, Leipzig, Germany., Santini V; University of Florence, Florence, Italy., Diez-Campelo M; Haematology Department, University Hospital Salamanca, Salamanca, Spain., Singh A; Cleveland Clinic, Cleveland, OH, USA., Jain AG; Cleveland Clinic, Cleveland, OH, USA., Aguirre LE; Dana Farber Cancer Institute, Boston, MA, USA., Tinsley-Vance SM; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Schwabkey ZI; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Chan O; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Xie Z; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Brunner AM; Dana Farber Cancer Institute, Boston, MA, USA., Kuykendall AT; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Bennett JM; University of Rochester Medical Center, Rochester, NY, USA., Buckstein R; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Bejar R; University of California San Diego, San Diego, CA, USA., Carraway HE; Cleveland Clinic, Cleveland, OH, USA., DeZern AE; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA., Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Halene S; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Hasserjian RP; Massachusetts General Hospital, Boston, MA, USA., Lancet J; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., List AF; Precision BioSciences, Durham, NC, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Odenike O; Leukemia Program, University of Chicago Medicine and University of Chicago Comprehensive Cancer Center, Chicago, IL, USA., Padron E; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Roboz GJ; New York-Presbyterian/Weill Cornell Medicine, New York, NY, USA., Stahl M; Dana Farber Cancer Institute, Boston, MA, USA., Sekeres MA; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Steensma DP; Ajax Therapeutics, Cambridge, MA, USA., Savona MR; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Taylor J; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Xu ML; Department of Pathology and Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA., Sweet K; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Sallman DA; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Nimer SD; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Hourigan CS; Virginia Tech FBRI Cancer Research Center, Washington, DC, USA., Wei AH; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Sauta E; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., D'Amico S; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Train, Milan, Italy., Asti G; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Castellani G; Department of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy., Delleani M; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Campagna A; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Borate UM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Sanz G; Instituto de Salud Carlos III, Valencia, Spain., Efficace F; Department of Haematology, La Fe University and Polytechnic Hospital, Valencia, Spain., Gore SD; Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA., Kim TK; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rozman M; Hospital Clínic Barcelona, Barcelona, Spain., Orfao A; Haematology Department, University Hospital Salamanca, Salamanca, Spain., Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Foucar MK; University of New Mexico, Albuquerque, NM, USA., Germing U; Department of Haematology, Oncology, and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Scheinberg P; Beneficência Portuguesa de São Paulo Hospital, São Paulo, Brazil., Miyazaki Y; Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan., Iastrebner M; Sanatorio Sagrado Corazón, Buenos Aires, Argentina., Kulasekararaj A; King's College Hospital NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK., Cluzeau T; Nice University Hospital, Nice, France., Kordasti S; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College, London, UK., van de Loosdrecht AA; Department of Hematology, Amsterdam University Medical Center, VU University Medical Center-Cancer Center, Amsterdam, Netherlands., Ades L; Saint Louis Hospital, Paris Cité University, Paris, France., Zeidan AM; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Della Porta MG; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy. Electronic address: matteo.della_porta@hunimed.eu.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 Oct 08. Date of Electronic Publication: 2024 Oct 08.
Autor:
Crisà E; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy. elena.crisa@ircc.it.; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy. elena.crisa@ircc.it., Mora E; Hospital Universitario y Politécnico La Fe, Instituto de Investigación Sanitaria La Fe, Valencia, Spain., Germing U; Department of Hematology, Oncology and Clinical Immunology, Universitätsklinik Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany., Bally C; Hématologie clinique, hôpital Necker. Assistance publique hôpitaux de Paris (APHP), Paris, France., Diez Campelo M; Hematology, Institute for Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, Salamanca, Spain., Myllymäki M; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Jädersten M; Department of Hematology M64 Karolinska University Hospital, Stockholm, Sweden., Komrokji R; Malignant Hematology Department, Moffitt Cancer Center, Tampa, FL, USA., Platzbecker U; Department of Hematology, Cellular Therapy,Hemostaseology and Infectiology, University Hospital Leipzig, Leipzig, Germany., Haase D; Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany., Hofmann WK; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Heidelberg, Germany., Al Ali NH; Malignant Hematology Department, Moffitt Cancer Center, Tampa, FL, USA., Barraco D; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; Dipartimento di Ematologia - ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy., Bargay JJ; Hematology Department. Hospital Son Llatzer, Mallorca, Spain., Bernal T; Hematology Department. Hospital Central de Asturias, Oviedo, Spain., López Cadenas F; Hematology Department. Hospital Clinico Universitario de Salamanca, Salamanca, Spain., Calvisi A; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; UOC Ematologia CTMO, Osp San Francesco Nuoro, Nuoro, Italy., Capodanno I; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; SOC Ematologia Azienda USL-IRCSS di Reggio Emilia, Reggio Emilia, Italy., Cerrano M; Hematology-University Hospital Città della Salute e della Scienza, Turin, Italy.; Hematology- Hospital Città della Salute e della Scienza, Turin, Italy., Ciancia R; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; IRCCS Centro di Riferimento Oncologico (CRO) di Aviano (Pordenone), Aviano, Italy., Crugnola M; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; Hematology Unit and BMT center University Hospital of Parma, Parma, Italy., Kündgen A; Department of Hematology, Oncology and Clinical Immunology, Universitätsklinik Düsseldorf, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany., Finelli C; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Institute of Hematology 'Seràgnoli', Bologna, Italy., Fozza C; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy., Frairia C; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; Hematology- Hospital Città della Salute e della Scienza, Turin, Italy., Freja E; Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland., Ganster C; Clinics of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany., Kubasch AS; Department of Hematology, Cellular Therapy,Hemostaseology and Infectiology, University Hospital Leipzig, Leipzig, Germany., Jimenez MJ; Hematology Department. Hospital Gemans Trias i Pujol, Badalona, Spain., Latagliata R; Unità Operativa Complessa (UOC) Ematologia, Ospedale Belcolle, Viterbo and Division of Cellular Biotechnology and Hematology, Sapienza University, Rome, Italy., Hernandez Mohedo F; Hematology Department. Hopital Unversitario Virgen de las Nieves, Granada, Spain., Molero A; Hematology Department. Hospital Universitario Vall D'Hebron, Barcelona, Spain., Vara Pampliega M; Hematology Department. Hospital de Cruces, Barakaldo, Spain., Perez CA; Hematology Department. Hospital Universitario Reina Sofia, Cordoba, Spain., Pietrantuono G; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; IRCCS CROB, Referral Cancer Center of Basilicata, Rionero In Vulture, Italy., Poloni A; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy.; Hematology, Università Politecnica Marche - AOU Marche, Ancona, Italy., Pomares H; Hematology Department. ICO Duran i Reynals, L'Hospitalet de LLobregat, LLobregat, Spain., Recasens V; Valle Recasens. Hematology Department. Hospital Miguel Servent, Zaragoza, Spain., Rüfer A; Division of Hematology, Luzerner Kantonsspital-in association with University Luzern, Luzern, Switzerland., Signori A; Department of Health Sciences - Section of Biostatistics University of Genoa, Genova, Italy., Hellstrom-Lindberg E; Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Fenaux P; Service d'Hématologie Séniors, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Sanz G; Hematology, Institute for Biomedical Research of Salamanca (IBSAL), University Hospital of Salamanca, Salamanca, Spain.; CIBERONC, ISCIII, Madrid, Spain., Santini V; Fondazione Sindromi Mielodisplastiche FISiM-ETS, Bologna, Italy. valeria.santini@unifi.it.; MDS Unit, Hematology, DMSC, AOU Careggi, University of Florence, Florence, Italy. valeria.santini@unifi.it.
Publikováno v:
Leukemia [Leukemia] 2024 Oct; Vol. 38 (10), pp. 2259-2265. Date of Electronic Publication: 2024 Aug 05.
Autor:
Tefferi A; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Fleti F; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Chan O; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Al Ali NH; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Al-Kali A; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Begna KH; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Foran JM; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Badar T; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Khera N; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Shah M; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Hiwase D; Division of Blood Cells and Blood Cancer, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia., Padron E; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Sallman DA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Pardanani A; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Arber DA; Department of Pathology, University of Chicago, Chicago, Illinois, USA., Orazi A; Department of Pathology, Texas Tech University Health Sciences Center, El Paso, Texas, USA., Reichard KK; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., He R; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Ketterling RP; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Gangat N; Mayo Clinic, Rochester/Jacksonville/Scottsdale, Minnesota/Florida/Arizona, USA., Komrokji R; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Apr; Vol. 204 (4), pp. 1243-1248. Date of Electronic Publication: 2023 Dec 11.
Autor:
Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Aguirre LE; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Al Ali NH; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Chan O; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Xie Z; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Kuykendall A; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Sweet K; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Lancet JE; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Padron E; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Sallman DA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
Publikováno v:
Blood advances [Blood Adv] 2023 Jul 25; Vol. 7 (14), pp. 3677-3679.
Autor:
Fleti F; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Chan O; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Singh A; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Abdelmagid MG; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Al-Kali A; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Elliott MA; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Begna KH; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Foran JM; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Badar T; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Khera N; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Al Ali NH; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Padron E; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Sallman DA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Shah M; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Hiwase D; Division of Blood Cells and Blood Cancer, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia., Pardanani A; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Arber DA; Department of Pathology, University of Chicago, Chicago, Illinois, USA., Orazi A; Department of Pathology, Texas Tech University Health Sciences Center, El Paso, Texas, USA., Reichard KK; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., He R; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Ketterling RP; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Gangat N; Mayo Clinic, Rochester, Minnesota, USA.; Mayo Clinic, Jacksonville, Florida, USA.; Mayo Clinic, Scottsdale, Arizona, USA., Komrokji R; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Tefferi A; Mayo Clinic, Rochester, Minnesota, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2023 Apr; Vol. 98 (4), pp. E76-E79. Date of Electronic Publication: 2023 Feb 06.
Autor:
Mangaonkar AA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester., Lasho TL; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester., Finke C; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester., Ketterling RP; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester., Reichard KK; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester., McCullough K; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester., Gangat N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester., Al-Kali A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester., Begna KH; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Hogan WH; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Litzow MR; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN., Alkhateeb H; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester., Shah M; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester., Pardanani A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester., Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester., Al Ali NH; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Talati C; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Sallman D; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Padron E; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL., Komrokji R; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL. Rami.Komrokji@moffitt.org., Patnaik MM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester. patnaik.mrinal@mayo.edu.
Publikováno v:
Haematologica [Haematologica] 2022 May 01; Vol. 107 (5), pp. 1189-1192. Date of Electronic Publication: 2022 May 01.
Autor:
Mangaonkar AA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA. mangaonkar.abhishek@mayo.edu., Lasho TL; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Ketterling RP; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Reichard KK; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Gangat N; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Al-Kali A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Begna KH; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Pardanani A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Al Ali NH; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Talati C; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Sallman D; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Padron E; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Patnaik MM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA., Tefferi A; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA. Tefferi.Ayalew@mayo.edu., Komrokji R; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA. Rami.Komrokji@moffitt.org.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2022 Feb 01; Vol. 12 (2), pp. 26. Date of Electronic Publication: 2022 Feb 01.
Autor:
Gajzer D; Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Logothetis CN; University of South Florida, Internal Medicine, Tampa, FL, USA., Sallman DA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Calon G; University of South Florida, College of Medicine, USA., Babu A; University of South Florida, Internal Medicine, Tampa, FL, USA., Chan O; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Vincelette ND; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Volpe VO; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Al Ali NH; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Basra P; Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Talati C; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Kuykendall AT; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Mo Q; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Padron E; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Sweet K; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Komrokji RS; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Lancet JE; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA., Yun S; Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA. Electronic address: Seongseok.Yun@moffitt.org., Zhang L; Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Electronic address: Ling.Zhang@moffitt.org.
Publikováno v:
Leukemia research [Leuk Res] 2021 Dec; Vol. 111, pp. 106733. Date of Electronic Publication: 2021 Oct 21.
Autor:
Sallman DA; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., DeZern AE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD., Garcia-Manero G; Department of Leukemia, MD Anderson Cancer Center, Houston, TX., Steensma DP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Roboz GJ; Weill Cornell Medicine and The New York Presbyterian Hospital, New York, NY., Sekeres MA; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH., Cluzeau T; Cote D'Azur University, Nice Sophia Antipolis University, Hematology Department, CHU Nice, Nice, France., Sweet KL; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., McLemore A; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., McGraw KL; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Puskas J; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Zhang L; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Yao J; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Mo Q; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Nardelli L; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Al Ali NH; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Padron E; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Korbel G; Aprea Therapeutics, Boston, MA., Attar EC; Aprea Therapeutics, Boston, MA., Kantarjian HM; Department of Leukemia, MD Anderson Cancer Center, Houston, TX., Lancet JE; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Fenaux P; Hospital St Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., List AF; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Komrokji RS; Malignant Hematology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 May 10; Vol. 39 (14), pp. 1584-1594. Date of Electronic Publication: 2021 Jan 15.
Autor:
Ward GA; Cancer Biology PhD Program, University of South Florida and H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., McGraw KL; Department of Malignant Hematology, and., Abbas-Aghababazadeh F; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Meyer BS; Department of Malignant Hematology, and., McLemore AF; Department of Malignant Hematology, and., Vincelette ND; Department of Malignant Hematology, and., Lam NB; Department of Malignant Hematology, and., Aldrich AL; Department of Malignant Hematology, and., Al Ali NH; Department of Malignant Hematology, and., Padron E; Department of Malignant Hematology, and., Pinilla-Ibarz J; Department of Malignant Hematology, and., Masala E; MDS Unit, Azienda Ospedaliero Universitaria Careggi, University of Florence, Firenze, Italy., Santini V; MDS Unit, Azienda Ospedaliero Universitaria Careggi, University of Florence, Firenze, Italy., Kosmider O; Assistance Publique-Hôpitaux de Paris, Centre-Université de Paris, Service d'Hématologie Biologique, Hôpital Cochin, Paris, France.; Groupe Francophone des Myélodysplasies, Hôpital Saint-Louis, Paris, France., Fontenay M; Assistance Publique-Hôpitaux de Paris, Centre-Université de Paris, Service d'Hématologie Biologique, Hôpital Cochin, Paris, France.; Groupe Francophone des Myélodysplasies, Hôpital Saint-Louis, Paris, France., Fenaux P; Groupe Francophone des Myélodysplasies, Hôpital Saint-Louis, Paris, France.; Service d'Hématologie Séniors, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris and Université Paris 7, Paris, France., Johnson J; Analytic Microscopy Core Facility, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; and., Fridley BL; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., List AF; Raleigh, NC.
Publikováno v:
Blood advances [Blood Adv] 2021 Apr 27; Vol. 5 (8), pp. 2216-2228.